Clinical study "common" name (formal title)	Number of enrollees (per protocol [PP]/intent-to-treat [ITT])	Funding source (pharmaceutical company/National Institutes of Health [NIH])	Year completed	Primary publication	Full study treatment protocol
The Prevalence of Myopic Choroidal Neovascularization in the United States	Complete data group: NHANES: 8,865 adults IRIS Registry: 2,622,400 adults	None	N/A	Willis JR, et al. The prevalence of myopic choroidal neovascularization in the United States: analysis of the IRIS Data Registry and NHANES. Ophthalmology. 2016;123(8):1771-1782. https://www.aaojournal.org/article/S0161-6420(16)30140-3/fulltext	N/A